26dkou244 10.3205/26dkou244 urn:nbn:de:0183-26dkou2445 Meeting Abstract Valentini Valentini Marisa M

Orthopaedics and Trauma, Medical University of Graz, Graz, Österreich

author Svehlik Svehlik Martin M

Orthopaedics and Trauma, Medical University of Graz, Graz, Österreich

author Leithner Leithner Andreas A

Orthopaedics and Trauma, Medical University of Graz, Graz, Österreich

author Bergovec Bergovec Marko M

Orthopaedics and Trauma, Diakonissen Schladming Clinic, Schladming, Österreich

author EMSOS TFR Study Group

Multiple, Italy, Turkey, Italy, Germany, South Africa, Israel, Finland, France, Portugal, Slovenja, Poland, Österreich

author Smolle Smolle Maria Anna MA

Orthopaedics and Trauma, Medical University of Graz, Graz, Österreich

author German Medical Science GMS Publishing House

Düsseldorf

610 20261020 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). M0659 244 Deutsche Gesellschaft für Orthopädie und Unfallchirurgie Deutsche Gesellschaft für Orthopädie und Orthopädische Chirurgie Deutsche Gesellschaft für Unfallchirurgie Berufsverband für Orthopädie und Unfallchirurgie Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2026) Abstracts | Tumorchirurgie 1 Berlin 20261020 20261023 DKOU26_Abs_2053 TextObjectives and questions: Total femur replacements (TFR) involve the replacement of the whole femoral bone, reconstruction of the hip and knee joints, and soft tissue reconstruction for function and joint stability. The aim of this multicentric European Musculo-Skeletal Oncology Society (EMSOS) study is to report on the functional outcome, quality of life, as well as gait analysis in patients with TFR.Material and methods: Retrospective data from 12 international participating centres was collected. 65 patients (median (IQR) age at surgery 40 (18–56) years, 60% male) who received a TFR due to oncologic or non-oncologic indications between 01.01.1990 and 31.03.2024 were included. Patient related outcome measures (PROMs), range of motion (ROM) of the hip and knee, and gait videos were collected.Results: At a median (IQR) follow-up of 28 months (14–126), the median (IQR) percentage MSTS score was 63% (43-73), SF-12 70% (55–79), HHS 63% (52–77), and OKS 63% (52–79); the median (IQR) extension-to-flexion ROM were 80° (70-97.5, hip) and 70° (40–90, knee). Gait videos were available for 24/65 patients (37%). The median (IQR) total Edinburgh visual gait score of the operated side was 8.5 (6–13), with deviations from norm in all patients (24/24). Compensational gait pathology on the contralateral side was detected in 23/24 patients (96%). Better outcome measures significantly correlated with younger age (all PROMs), oncologic indications (MSTS and OKS), and primary TFR implantations (MSTS).Discussion and conclusions: Moderate to good PROM scores are to be expected after TFR, with better outcome in younger patients, undergoing primary implantations, for oncologic indications. The recurrent gait deviations observed and the compensational gait pathology on the contralateral side should be considered in TFR aftercare, remobilisation and patient counselling. 0 0 0 0